biopsy-proven WHO Class IV lupus nephritis, and positivity for antinuclear antibodies and antibodies to double-stranded DNA. During the index hospitalization, the patient's medications included ...

RubrYc’s lead programs include RTX-002, an anti-PD-1 agonist for serious autoimmune diseases such as systemic lupus erythematosus and multiple sclerosis, and RTX-003, an anti-CD25 antibody that ...

Two other immunologic markers were recognized in the 1950s as being associated with lupus: the biologic false-positive test for syphilis and the immunofluorescent test for antinuclear antibodies.

Systemic Lupus Erythematosus (SLE)-lupus for short-is a chronic, painful and debilitating disease in which the antibodies produced by the immune system mistakenly attack the body's own tissues.

Belimumab, a humanized monoclonal antibody targeted against BLyS, is licensed for the management of lupus in the USA and Europe. A Phase III lupus trial showed that it was more efficacious ...

Systemic Lupus Erythematosus (SLE)—lupus for short—is a chronic, painful and debilitating disease in which the antibodies produced by the immune system mistakenly attack the body’s own tissues.

Systemic Lupus Erythematosus (SLE)—lupus for short—is a chronic, painful and debilitating disease in which the antibodies produced by the immune system mistakenly attack the body's own tissues.

Type B insulin resistance syndrome can develop when autoimmune antibodies or autoantibodies in lupus attack insulin receptor sites. While this primarily results in severe hyperglycemia (elevated ...

Read More: The Most Exciting New Advancements in Managing and Treating Lupus In response to a threat, such as a virus or other pathogen, the immune system produces protein antibodies that are ...

Patients with systemic lupus erythematosus (SLE ... Because antiphospholipid antibodies are known to be associated with CVD events in the general population, the lack of testing for ...